Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America. [electronic resource]
Producer: 20171207Description: 700-12 p. digitalISSN:- 1573-2592
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Bacterial Infections -- etiology
- Child
- Child, Preschool
- Female
- Humans
- Immunoglobulins, Intravenous -- administration & dosage
- Immunologic Deficiency Syndromes -- complications
- Infusions, Subcutaneous
- Male
- Middle Aged
- Quality of Life
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.